MICAR21.COM: Keyword Density Checker

Total words: 3925 | 2-word phrases: 1032 | 3-word phrases: 1164 | 4-word phrases: 1196

PAGE INFO

Title	Try to keep the title under 60 characters (68 characters) Micar21.com - Drug Discovery Factory - Drug Discovery faster in days
Description	Try to keep the meta description between 50 - 160 characters (266 characters) Micar21.com - Drug Discovery Factory - Drug Discovery faster in days, In silico drug discovery, Drug discovery faster, Drug discovery, Molecular modelling, FEP+, Lead optimization, Hit compounds discovery, Docking, Pharmachophore, Molecular dynamics, Bioinformatics
Keywords	Meta keywords are not recommended anymore (266 characters) Micar21.com, Drug Discovery Factory, Drug Discovery faster in days, In silico drug discovery, Drug discovery faster, Drug discovery, Molecular modelling, FEP+, Lead optimization, Hit compounds discovery, Docking, Pharmachophore, Molecular dynamics, Bioinformatics
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	selectivity and admet	5	0.43%
2	low toxic potential	3	0.26%
3	preclinical phase with	3	0.26%
4	etc to validate	3	0.26%
5	predictions of activity	3	0.26%
6	potential etc to	3	0.26%
7	activity selectivity and	3	0.26%
8	ai drug discovery	3	0.26%
9	penetration low toxic	3	0.26%
10	advanced predictions of	3	0.26%
11	free energy perturbation	3	0.26%
12	toxic potential etc	3	0.26%
13	insight into pparγ	2	0.17%
14	with advanced predictions	2	0.17%
15	virtual screening approach	2	0.17%
16	of activity selectivity	2	0.17%
17	structural and dynamical	2	0.17%
18	simulations structural and	2	0.17%
19	dynamics simulations structural	2	0.17%
20	is mediated by	2	0.17%
21	by receptor dimerization	2	0.17%
22	mediated by receptor	2	0.17%
23	than 70 success	2	0.17%
24	receptor is mediated	2	0.17%
25	orientation of estrogen	2	0.17%
26	micar21 ai drug	2	0.17%
27	and docking virtual	2	0.17%
28	pharmacophore and docking	2	0.17%
29	based pharmacophore and	2	0.17%
30	of structural based	2	0.17%

#	Keyword	Frequency	Density
1	activity selectivity and admet	3	0.25%
2	potential etc to validate	3	0.25%
3	toxic potential etc to	3	0.25%
4	low toxic potential etc	3	0.25%
5	penetration low toxic potential	3	0.25%
6	than 70 success rate	2	0.17%
7	predictions of activity selectivity	2	0.17%
8	advanced predictions of activity	2	0.17%
9	with advanced predictions of	2	0.17%
10	based virtual screening approach	2	0.17%
11	modes with a similar	2	0.17%
12	binding modes with a	2	0.17%
13	mutable binding modes with	2	0.17%
14	dynamics simulations structural and	2	0.17%
15	antagonists exhibit mutable binding	2	0.17%
16	noncovalent antagonists exhibit mutable	2	0.17%
17	exhibits an antagonist conformation	2	0.17%
18	an antagonist conformation pparγ	2	0.17%
19	12 exhibits an antagonist	2	0.17%
20	helix 12 exhibits an	2	0.17%
21	prediction of accurate binding	2	0.17%
22	pparγ helix 12 exhibits	2	0.17%
23	modes using combination of	2	0.17%
24	using combination of classical	2	0.17%
25	based pharmacophore and docking	2	0.17%
26	calculations an application to	2	0.17%
27	combination of structural based	2	0.17%
28	receptor is mediated by	2	0.17%
29	is mediated by receptor	2	0.17%
30	mediated by receptor dimerization	2	0.17%
31	the free energy perturbation	2	0.17%
32	free energy perturbation fep	2	0.17%
33	of activity selectivity and	2	0.17%
34	exhibit mutable binding modes	2	0.17%
35	simulations structural and dynamical	2	0.17%
36	micar21 ai drug discovery	2	0.17%
37	etc to validate nonclinical	2	0.17%
38	studies discovery of new	2	0.17%
39	refined structure absorptions membrane	2	0.17%
40	of binding a case	2	0.17%

#	URL	Whois	Check
1	https://pubs.acs.org/doi/10.1021/acs.jcim.1c01242	Whois	acs.org
2	https://www.biorxiv.org/content/10.1101/2020.12.23.424283v2	Whois	biorxiv.org
3	https://www.biorxiv.org/content/10.1101/2021.10.12.463781v1	Whois	biorxiv.org
4	https://www.linkedin.com/company/micar21	Whois	linkedin.com
5	https://twitter.com/Micar21Ltd	Whois	twitter.com